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Interventional Cardiology
Atorvastatin Reduces Microinfarction
Rates After PCI: Role of Adhesion Molecules
In the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during An-gioplasty) trial, 7 days of pre-treatment with atorvastatin prior to percutaneous
coronary intervention (PCI) reduced the rate of peri-procedural myocardial infarction
by 80%. Adhesionmolecules are proteins located along the membranes of endothelial
cells that facilitate adhesion and translocation of leukocytes. For this substudy, partic-
ipants at one center had serial blood draws for determination of serum levels of
adhesion molecules. There was no change in serum levels of these molecules with
atorvastatin prior to PCI, but post-PCI increases of intercellular cell adhesion
molecule-1 and E-selectin were significantly lower. This study suggests that pre-
treatment with atorvastatin may reduce the inflammatory endothelial response in-
duced by PCI and thereby lead to lower rates of peri-procedural micro infarctions.
See page 1560. See figure.
Heart Failure
Polyunsaturated Fatty Acids Restore
Baroreceptor Sensitivity in Heart Failure Patients
Dietary supplementation with N-3 polyunsaturated fatty acids (PUFA) has beenshown to reduce the risk of life-threatening arrhythmias in post-myocardial
infarction (post-MI) patients. Radaelli and colleagues performed sensitive measure-
ments of heart rate variability and arterial baroreceptor function in a small sample of
post-MI patients with reduced left ventricular (LV) functionwhowere given either 2 g
of PUFA daily or placebo. Those treated with PUFA had evidence of restored barore-
ceptor reflexes and enhanced heart rate variability. This study shows that dietary
supplementation with PUFA helps to restore normal heart rate variability in subjects
with LV dysfunction. See page 1600.
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Heart Failure
High BNP, Low GFR Predicts High Risk in Heart Failure
The relationship between amino-terminal pro-brain natriuretic peptide (NT-proBNP), structural heart disease, and renal function remains incompletely
understood. Kimmenade and colleagues studied these interactions in over 700 subjects
hospitalized with heart failure and followed for 60 daymortality. The odds ratio (OR)
for death with a glomerular filtration rate (GFR) below the median (60 ml/min/
1.73m2) was 2.0; the OR for anNT-proBNP concentration above themedian (4,647
pg/ml) was 2.7. The OR for those with both an elevated NT-pro BNP and a reduced
GFR was 3.5. The combination of serum NT-proBNP and an estimate of renal
function better predicts short-termmortality for subjects with heart failure than either
parameter alone. See page 1621. See figure.
(continued) A-40Pacing and Cardiac Function
Optimizing Hemodynamics and Outcomes After Pacemaker Implantation
Three articles and an editorial in this issue study the interaction between baselineclinical characteristics and outcomes after pacemaker implantation. Hayes and
colleagues examined data from the DAVID trial that showed worse outcomes in
patients referred for implantable cardioverter-defibrillators who were randomized to a
DDDR-70 setting versus a VVI-40mode. The increasedmortality was only present in
those with a baseline QRS110 ms, suggesting that the risk of deterioration is only
present in those with underlying conduction system disease. Lieberman and colleagues
performed left ventricular (LV) pressure volume loop recordings on patients referred
for electrophysiologic testing with variable pacing sites. Right ventricular (RV) pacing
worsened LV function in patients with and without LV dysfunction, whereas LV or
biventricular pacing preserved or improved LV function. In the third article, Tops and
colleagues studied 55 patients who underwent atrioventricular nodal ablation and
subsequent RV pacemaker implantation. One-half of patients developed evidence of
LV dyssynchrony; these patients had higher New York Heart Association functional
class scores and lower ejection fractions than those who did not develop dyssynchrony.
An editorial by Tse and Lau summarizes the evidence and controversies regarding the
selection of the optimal pacing site. See pages 1628, 1634, 1642, and 1649.
Cardiac Imaging
64-Slice CTA Versus Angiography Prior to Valve Surgery
As the diagnostic accuracy of computed tomographic angiography (CTA) im-proves, the prospective indications are expanding. Investigators from theThorax-
center studied patients referred for elective valve surgery with both CTA and conven-
tional coronary angiography (CCA). Using a 64-slice scanner, they were able to
identify all patientswith significant (50%) coronary stenosis. Four patients (8%)had
CTAs interpreted as showing a significant stenosis, but only luminal irregularities on
CCA. If this study had been set up as a protocol withCTA as an initial screening, 69%
of patients would avoid CCA, 26% would have CCA to confirm the findings from
CTA, and in only 6%would an “unnecessary” CCAbe performed.See page1658.
